Maravai Lifesciences Holdings Inc (MRVI) — Cash Flow Reinvestment Rate
Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow Reinvestment Rate of 1.41x as of September 2024, reinvesting $18.55 Million (capex $9.59 Million plus investments $-8.96 Million) from operating cash flow of $13.14 Million. Check MRVI cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Maravai Lifesciences Holdings Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Maravai Lifesciences Holdings Inc across 6 annual periods. Explore cash flow to debt ratio of Maravai Lifesciences Holdings Inc to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Maravai Lifesciences Holdings Inc (2019–2024)
Year-by-year capital reinvestment analysis for Maravai Lifesciences Holdings Inc. For live market cap and broader valuation context, see MRVI market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.23x | $53.97 Million | $7.46 Million | $29.66 Million | ▲ +371.7% |
| 2023 | 1.53x | $193.48 Million | $126.22 Million | $65.55 Million | ▲ +188.6% |
| 2022 | 0.53x | $284.70 Million | $535.98 Million | $17.09 Million | ▲ +62.5% |
| 2021 | 0.33x | $120.50 Million | $368.57 Million | $14.85 Million | ▲ +58.1% |
| 2020 | 0.21x | $31.48 Million | $152.19 Million | $25.41 Million | ▼ -85.5% |
| 2019 | 1.42x | $34.30 Million | $24.11 Million | $17.15 Million | — |